PKU HealthCare Corp Ltd - Asset Resilience Ratio
PKU HealthCare Corp Ltd (000788) has an Asset Resilience Ratio of 10.92% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is PKU HealthCare Corp Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2010–2014)
This chart shows how PKU HealthCare Corp Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 000788 total asset value.
Liquid Assets Composition Over Time
This chart breaks down PKU HealthCare Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of PKU HealthCare Corp Ltd to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥210.04 Million | 10.92% |
| Total Liquid Assets | CN¥210.04 Million | 10.92% |
Asset Resilience Insights
- Moderate Liquidity: PKU HealthCare Corp Ltd has 10.92% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
PKU HealthCare Corp Ltd Industry Peers by Asset Resilience Ratio
Compare PKU HealthCare Corp Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Jiuzhitang Co Ltd
SHE:000989 |
Drug Manufacturers - Specialty & Generic | 7.86% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for PKU HealthCare Corp Ltd (2010–2014)
The table below shows the annual Asset Resilience Ratio data for PKU HealthCare Corp Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2014-12-31 | 0.02% | CN¥745.36K ≈ $109.07K |
CN¥4.61 Billion ≈ $674.89 Million |
+0.01pp |
| 2013-12-31 | 0.01% | CN¥408.53K ≈ $59.78K |
CN¥4.23 Billion ≈ $618.84 Million |
-0.04pp |
| 2011-12-31 | 0.05% | CN¥1.28 Million ≈ $187.12K |
CN¥2.75 Billion ≈ $401.81 Million |
+0.04pp |
| 2010-12-31 | 0.00% | CN¥37.81K ≈ $5.53K |
CN¥1.98 Billion ≈ $289.61 Million |
-- |
About PKU HealthCare Corp Ltd
PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment se… Read more